Cargando…

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease. We investigated whether pre-cancer platelet count alone or togethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensvoll, Hilde, Blix, Kristine, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958406/ https://www.ncbi.nlm.nih.gov/pubmed/24642868 http://dx.doi.org/10.1371/journal.pone.0092011

Ejemplares similares

White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study
por: Blix, Kristine, et al.
Publicado: (2013)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
por: Leknessund, Oda G. R., et al.
Publicado: (2022)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
por: Børvik, Trond, et al.
Publicado: (2020)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018)

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism
por: Isaksen, Trond, et al.
Publicado: (2018)

Hand grip strength in venous thromboembolism: risk of recurrence and mortality
por: Leknessund, Oda G.R., et al.
Publicado: (2023)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
por: Tøndel, Birgitte G., et al.
Publicado: (2022)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
por: Meknas, Dana, et al.
Publicado: (2023)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension
por: Jørgensen, Helle, et al.
Publicado: (2022)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort
por: Jensvoll, Hilde, et al.
Publicado: (2015)

Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study
por: Grimnes, Gro, et al.
Publicado: (2017)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study
por: Grimnes, Gro, et al.
Publicado: (2018)

Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
por: Jørgensen, Helle, et al.
Publicado: (2021)

Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
por: Arnesen, Carl Arne Løchen, et al.
Publicado: (2021)

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
por: Paulsen, Benedikte, et al.
Publicado: (2020)

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study
por: Solomon, Terry, et al.
Publicado: (2016)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
por: Lappegård, Jostein, et al.
Publicado: (2018)

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study
por: Morelli, Vânia M., et al.
Publicado: (2019)

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
por: Paulsen, Benedikte, et al.
Publicado: (2021)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
por: Gade, Inger Lise, et al.
Publicado: (2018)

Systemic inflammatory response syndrome and platelet count ≥250×10(9) are associated with venous thromboembolic disease
por: Pate, Amy, et al.
Publicado: (2015)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019
por: Marvi, Tanya K., et al.
Publicado: (2021)

Serum osteoprotegerin levels are related to height loss: The Tromsø Study
por: Jørgensen, Lone, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5bqt6kuhotqbv97iclm78pkf1h